Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Colvera for Detection of Disease Recurrence

ClinicalTrials.gov ID: NCT03706235

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03706235. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 18, 2026, 4:22 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Evaluation of the Performance of the Clinical Genomics Colvera Test in the Detection of Disease Recurrence in Patients Diagnosed With Colorectal Cancer- "NOVA"

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To compare the sensitivity and specificity estimates of Colvera with that of a commercially available CEA test for detection of recurrent disease in CRC subjects who are undergoing surveillance for recurrence.

Study identification

NCT ID
NCT03706235
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Clinical Genomics Pathology
Industry
Enrollment
488 participants

Conditions and interventions

Interventions

Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 1, 2018 (Actual)
Primary completion
Aug 16, 2019 (Actual)
Completion
Apr 29, 2020 (Actual)
Last update posted
Jul 14, 2020

2018 – 2020

United States locations

U.S. sites
12
U.S. states
11
U.S. cities
12
Facility City State ZIP Site status
Torrance Memorial Physician Network Redondo Beach California 90277 —
Bayhealth Dover Delaware 19901 —
Rush University Medical Center Chicago Illinois 60612 —
NorthShore Health System Evanston Illinois 60201 —
Indiana University Indianapolis Indiana 46202 —
Colon and Rectal Surgery Associates Metairie Louisiana 70001 —
Providence Hospital-Ascension Health Novi Michigan 48374 —
Virginia Piper Cancer Institute-Allina Health Minneapolis Minnesota 55407 —
Essex Oncology Belleville New Jersey 07109 —
Roswell Park Cancer Institute Buffalo New York 14263 —
University Hospitals Cleveland Ohio 44106 —
Baylor College of Medicine Houston Texas 77030 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03706235, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 14, 2020 · Synced Nov 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.